Evidence map›Paper›PMID 40828879›Full record

ArticlePLoS computational biology2025

Leaky or polarised immunity: Non-Markovian modelling highlights the impact of immune memory assumptions.

Bastien Reyné, Tsukushi Kamiya, Ramsès Djidjou-Demasse, Samuel Alizon, Mircea T Sofonea

Abstract read
In one paragraph

Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bastien ReynéUniv. Bordeaux, INSERM, INRIA, BPH, U1219, Bordeaux, France.ORCID 0000-0002-4899-1240
Tsukushi KamiyaCIRB, Collège de France, CNRS, INSERM, Université PSL, Paris, France.
Ramsès Djidjou-DemasseMIVEGEC, Univ. Montpellier, CNRS, IRD, Montpellier, France.
Samuel AlizonCIRB, Collège de France, CNRS, INSERM, Université PSL, Paris, France.
Mircea T SofoneaPCCEI, Univ Montpellier, INSERM, Montpellier, France.

Funding

ANRS Maladies Infectieuses Émergentes and France 2030ExposUM Institute of the University of MontpellierFrance 2030 programmeOccitanie Region
6 · The paper itself

Abstract

Mathematical models tend to oversimplify the biological details of vaccine or infection-derived immunity effectiveness. Yet, epidemiological outcomes may diverge when assuming polarised immunity-individuals are either fully susceptible or completely immune-compared to leaky immunity-where all individuals are partially protected. We explore the differences between the two by taking advantage of a non-Markovian framework, which allows us to explicitly record the 'age' of the immunity and vary its effectiveness accordingly. A basic scenario reveals that leaky immunity leads to a shorter time between reinfections. A more data-driven scenario based on SARS-CoV-2 data finds that leaky immunity yields substantially more reinfections than polarised immunity and a higher number of infected individuals, yet with a lower probability of hospitalisation. Our findings emphasize the critical role of immune memory modelling assumptions, especially for long-term epidemiological dynamics and public health policies.

Indexed as

COVID-19Immunologic MemoryModels, ImmunologicalComputational BiologyCOVID-19 VaccinesHumansMarkov ChainsReinfectionSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID40828879
PMCPMC12407549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.